tirzepatide fda obesity grants fast track designation to tirzepatide, Eli Lilly's new type 2 diabetes drug, for treating Tirzepatide is FDA-approved for weight

This may indicate a dose that is too aggressive for your body, a nutritional deficiency that needs correction, an underlying condition that the medication is unmasking, or severe caloric restriction similar to what causes paradoxical weight gain through metabolic adaptation

doi: 10.1038/s41598-020-77105-y 412 ReuterSEEvansAM

Your Precision Peptide Genetic Test can help identify genetic predispositions to side effect sensitivity, allowing PlexusDx providers to personalize your starting dose and escalation plan

Most men tolerate peptide therapy well when dosed appropriately and supervised by a qualified physician, but this requires regular check-ins-not a one-time consultation followed by self-directed use